India's pharma industry saves US healthcare $219 billion in 2022

India's pharmaceutical industry saved the US healthcare system $219 billion in 2022, according to Union Health Secretary Punya Salila Srivastava. India is the third-largest producer of generic medicines and has the most US FDA-approved pharmaceutical plants outside the US. India manufactured 4 billion of the 8 billion vaccine doses produced globally last year. The country has also reformed medical education, increasing the number of medical and nursing colleges to address healthcare professional shortages. India and the US are collaborating on health initiatives, including cancer research and pandemic preparedness. They have launched the US-India Cancer Moonshot Dialogue and the Bio-5 alliance to optimize the biopharmaceutical supply chain.